Head-to-head · WeighScore
OlleveCare vs Vea Health
The verdict
Vea Health takes it — 55/100 to 46.2/100.
Vea Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Vea Health is a direct-to-consumer telehealth platform aimed at men's health, performance, and longevity, offering compounded semaglutide and tirzepatide in both oral and injection protocols.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | OlleveCare | Vea Health |
|---|---|---|
| WeighScore | 46.2/100 | 55/100 |
| Grade | C | C |
| Scorecard rank | #497 | #450 |
| Semaglutide | Not disclosed | Not disclosed |
| Tirzepatide | Not disclosed | Not disclosed |
| Coverage | 13 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #497 · C
Strengths
- 13 states listed explicitly (VA, FL, AZ, MA, HI, IA, MD, NM, WA, KS, NY, DC, ID)
- Both semaglutide and tirzepatide offered — switch molecules without switching platforms
- Multi-service platform — GLP-1, virtual urgent care, and non-controlled refills with one provider
- Cash-pay with a superbill option for out-of-network reimbursement
- Founder Ahmed Emam is named in the footer
Where it loses points
- Legal entity name not disclosed anywhere — can't be verified in a state registry
- Pricing not shown before booking — you must enter the intake flow to see the fee
- Pharmacy partner not named; model appears to fill at your preferred retail pharmacy
- No medical director or prescribing clinician named — only 'board-certified providers'
- No LegitScript badge, BBB profile, or HIPAA/SOC 2 seals displayed
Graded #450 · C
Strengths
- Publishes the FDA compounded-medication disclaimer
- Oral and injection protocols for both semaglutide and tirzepatide
- Claims 50-state coverage via a clinician network
- Clearly differentiated positioning (longevity, men's health, performance)
Where it loses points
- Pricing not shown until after sign-up
- Pharmacy partner not named (only 'U.S.-based pharmacy')
- LegitScript certification status not visible
- No named medical director
- 503A vs 503B designation not specified
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.